Literature DB >> 23436321

Use of colonoscopy for polyp surveillance in Medicare beneficiaries.

Gregory S Cooper1, Tzuyung D Kou, Jill S Barnholtz Sloan, Siran M Koroukian, Mark D Schluchter.   

Abstract

BACKGROUND: Professional society guidelines recommend follow-up colonoscopy for patients with resected colonic adenomas. However, adherence to guideline recommendations in routine clinical practice has not been well characterized.
METHODS: The authors used a population-based sample of Medicare beneficiaries to identify all patients aged ≥70 years who had a claim for colonoscopy with polypectomy or hot biopsy during the period from 2001 to 2004. Medicare claims through 2009 identified colonoscopy within the following 5 years as well as fecal occult blood testing, sigmoidoscopy, and barium enema.
RESULTS: In total, 12,771 patients were included. At 5 years, 45.7% of patients underwent another colonoscopy, and 32.3% of procedures included a polypectomy. The rates of fecal occult blood testing, flexible sigmoidoscopy, and barium enema at 5 years were 54%, 3.8%, and 2.9%, respectively. There was a marked decrease in repeat colonoscopy at 1 year, 3 years, and 5 years with more recent years of index procedures. Other predictors of undergoing repeat colonoscopy were younger age, African American race, and a colonoscopy before the index examination. There was no association with physician specialty. The decreasing use of colonoscopy with time was maintained in a multivariable analysis.
CONCLUSIONS: In a sample of elderly Medicare beneficiaries, there was under use of follow-up colonoscopy at 5 years after polypectomy, and <50% of patients received a repeat examination. In particular, the use of this procedure decreased over the 4-year study period. Coupled with other data indicating the overuse of follow-up colonoscopy in patients without polyps, there appeared to be significant discordance between guidelines and actual practice.
Copyright © 2013 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436321      PMCID: PMC3648624          DOI: 10.1002/cncr.27990

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Geographic variation in Medicare drug spending.

Authors:  Yuting Zhang; Katherine Baicker; Joseph P Newhouse
Journal:  N Engl J Med       Date:  2010-06-09       Impact factor: 91.245

2.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

3.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

4.  Overuse of screening colonoscopy in the Medicare population.

Authors:  James S Goodwin; Amanpal Singh; Nischita Reddy; Taylor S Riall; Yong-Fang Kuo
Journal:  Arch Intern Med       Date:  2011-05-09

5.  Regional variations in diagnostic practices.

Authors:  Yunjie Song; Jonathan Skinner; Julie Bynum; Jason Sutherland; John E Wennberg; Elliott S Fisher
Journal:  N Engl J Med       Date:  2010-05-12       Impact factor: 91.245

6.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

7.  Accuracy of Medicare claims for identifying findings and procedures performed during colonoscopy.

Authors:  Cynthia W Ko; Jason A Dominitz; Pam Green; William Kreuter; Laura-Mae Baldwin
Journal:  Gastrointest Endosc       Date:  2010-10-15       Impact factor: 9.427

8.  Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial.

Authors:  Adeyinka O Laiyemo; Paul F Pinsky; Pamela M Marcus; Elaine Lanza; Amanda J Cross; Arthur Schatzkin; Robert E Schoen
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-13       Impact factor: 11.382

9.  Utilization of surveillance colonoscopy in community practice.

Authors:  Robert E Schoen; Paul F Pinsky; Joel L Weissfeld; Lance A Yokochi; Douglas J Reding; Richard B Hayes; Timothy Church; Susan Yurgalevich; V Paul Doria-Rose; Tom Hickey; Thomas Riley; Christine D Berg
Journal:  Gastroenterology       Date:  2009-10-08       Impact factor: 22.682

10.  Assessing comorbidity using claims data: an overview.

Authors:  Carrie N Klabunde; Joan L Warren; Julie M Legler
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  19 in total

Review 1.  Colorectal Cancer Screening and Surveillance Colonoscopy in Older Adults.

Authors:  Jennifer K Maratt; Audrey H Calderwood
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

2.  Overuse of colonoscopy for colorectal cancer screening and surveillance.

Authors:  Gina R Kruse; Sami M Khan; Alan M Zaslavsky; John Z Ayanian; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2014-09-30       Impact factor: 5.128

3.  Patient-, provider-, and system-level factors in low adherence to surveillance colonoscopy guidelines: implications for future interventions.

Authors:  Caitlyn Braschi; Debra J Pelto; Marie O Hennelly; Kristen K Lee; Brijen Shah; Guy H Montgomery; Steven H Itzkowitz; Lina Jandorf
Journal:  J Gastrointest Cancer       Date:  2014-12

4.  Impact of a Clinical Decision Support System on Guideline Adherence of Surveillance Recommendations for Colonoscopy After Polypectomy.

Authors:  Melissa Magrath; Edward Yang; Chul Ahn; Christian A Mayorga; Purva Gopal; Caitlin C Murphy; Samir Gupta; Deepak Agrawal; Ethan A Halm; Eric K Borton; Celette Sugg Skinner; Amit G Singal
Journal:  J Natl Compr Canc Netw       Date:  2018-11       Impact factor: 11.908

5.  Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.

Authors:  Amit G Singal; Samir Gupta; Celette Sugg Skinner; Chul Ahn; Noel O Santini; Deepak Agrawal; Christian A Mayorga; Caitlin Murphy; Jasmin A Tiro; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Adam C Loewen; Ethan A Halm
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

6.  Predictors of guideline concordance for surveillance colonoscopy recommendations in patients at a safety-net health system.

Authors:  Ben Kahn; Zachary Freeland; Purva Gopal; Deepak Agrawal; Christian A Mayorga; Rozina Mithani; Celette Sugg Skinner; Ethan A Halm; Amit G Singal
Journal:  Cancer Causes Control       Date:  2015-09-16       Impact factor: 2.506

Review 7.  Colorectal cancer screening quality, cost and practice in an era of healthcare transformation.

Authors:  Martin Brotman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

8.  Underuse and Overuse of Colonoscopy for Repeat Screening and Surveillance in the Veterans Health Administration.

Authors:  Caitlin C Murphy; Robert S Sandler; Janet M Grubber; Marcus R Johnson; Deborah A Fisher
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-19       Impact factor: 11.382

9.  Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity.

Authors:  Djenaba A Joseph; Reinier G S Meester; Ann G Zauber; Diane L Manninen; Linda Winges; Fred B Dong; Brandy Peaker; Marjolein van Ballegooijen
Journal:  Cancer       Date:  2016-05-20       Impact factor: 6.860

Review 10.  Disparities in endoscopy use for colorectal cancer screening in the United States.

Authors:  Andrew J Gawron; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2013-11-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.